Alex Kelly

Alex has a Bachelor of Science in Applied Biological Sciences with over 20 years’ experience in pharmaceutical development, obtained across several large pharmaceutical companies. His recent experience includes working to bring the first licensed cannabinoid medication to the US market with GW Pharmaceuticals and managing the clinical operations for Nova Laboratories. Alex’s expertise includes project management, operational performance metrics, leading global teams and managing global clinical trials.

Alex joined Small Pharma in 2022 as Senior Clinical Operations Manager to oversee the company’s Phase IIb trial. He is dedicated and passionate about bringing new medications to the market where there is an unmet need.

Learn more about Alex Kelly in his Small Pharma’s Big Minds conversation as he discusses his role at the company and why he is passionate about Small Pharma’s work in mental health.